# Long-term Weight Loss Effects of Semaglutide in Obesity Without Diabetes in the SELECT Trial ### Key Points: – The recent SELECT trial studied the long-term effects of semaglutide for weight loss in individuals with obesity but without diabetes. – Participants who took semaglutide lost an average of 15.3% of their body weight, compared to those who took a placebo and lost only 2.4%. – The study showed that semaglutide can be a promising treatment for obesity, as it led to a significant reduction in body weight and improved overall health. – Semaglutide works by reducing appetite and caloric intake, which contributes to its effectiveness in aiding weight loss over an extended period of time. Semaglutide has proven to be a game-changer in the world of weight loss, especially for individuals struggling with obesity. The significant reduction in body weight seen in the SELECT trial participants offers hope for those looking to achieve long-term weight loss goals. If you are interested in exploring semaglutide further to support your weight loss journey, consider reaching out to Mindful Evolution for guidance and support on incorporating this treatment option into your plan. *Weight Loss Disclaimer: Individual results may vary. Mindful Evolution offers telehealth services in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia.* Contact Mindful Evolution on our website https://yourmindfulevolution.com or call or text us at 954-639-9960 for more information or to schedule a consultation.